Conquering Diseases

Study Of An Investigational Drug For Irritability Associated With Autism Spectrum Disorder

Description

Seeking children aged 5 to 17 with autism spectrum disorder (ASD) for a study of an investigational drug to reduce the severity of irritability such as tantrums, aggression, yelling, self-injuring behavior, or quickly changing moods

Overview

Participants in this study will be randomly assigned to get either a high dose or low dose of the investigational drug or a placebo (looks like the investigational drug but contains no medicine) taken as a daily capsule or tablet over 6 weeks. There will be up to 9 study visits over 9 weeks.

What we're hoping for

We are studying if an investigational drug is safe and effective in reducing the severity of irritability like tantrums, aggression, yelling, self-injuring behavior, or quickly changing moods for children aged 5 to 17 with Autism Spectrum Disorder

Additional Information

ClinicalTrials.gov Identifier: NCT06690398

 Principal Investigator

David  Cochran, MD

UMass Chan Medical School

 Study Contact

Gregory  Bourbeau

gregory.bourbeau@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989